New drug shows promise for Hard-to-Treat back pain
Disease control
Not yet recruiting
This study tests a new drug called xeligekimab for people with non-radiographic axial spondyloarthritis, a condition that causes long-term back pain and stiffness. About 40 adults who have not responded well to standard anti-inflammatory drugs will receive injections of xeligekim…
Phase: PHASE2, PHASE3 • Sponsor: Lingli Dong • Aim: Disease control
Last updated May 08, 2026 12:03 UTC